preterm birth prevention
Women's health · 2020–2021
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| progesterone Prevention of preterm birth in singleton pregnancies at risk due to shortened cervix (midtrimester sonographic cervix ≤25 mm) and/or where there is a history… | Nov 2021 | Recommended with restriction | none received |
| progesterone Prevention of preterm birth in women with singleton pregnancies and a short cervix (≤25 mm) and/or a history of preterm birth. | Nov 2020 | Recommended with restriction | input received Preterm Infants Parents Association · Australian Preterm Birth Alliance · Australian Preterm Birth Prevention Alliance |
| progesterone Prevention of preterm birth in women with singleton pregnancies and a short cervix (≤25 mm) and/or a history of spontaneous preterm birth. | Nov 2020 | Recommended with restriction | none received |
Who spoke
Preterm Infants Parents Association · Australian Preterm Birth Alliance · Australian Preterm Birth Prevention Alliance
What the PBS pays
$10M in government benefit over 2024–25, across 166,811 services.
This is spend on the medicines considered for this condition, not spend on the disease. A medicine used for several conditions is counted in full under each, so figures across conditions add to more than national PBS expenditure.
| Medicine | Government benefit |
|---|---|
| progesterone | $9.6M |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 3 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.